Stryker's first-quarter 2026 earnings miss was notable, but the market's focus is rightly on the 'why' rather than the numbers themselves.
The company reported an adjusted EPS of $2.60 and revenue of $6.00 billion, falling short of analyst expectations. However, it's important to note that revenue still grew over 2% compared to the previous year, suggesting that underlying demand for its medical devices remains solid. The miss wasn't about customers buying less, but about Stryker's inability to ship products.
The primary cause was a major cyberattack in March. This incident crippled the company's corporate network, including its critical ordering and shipping systems, at the worst possible time—the end of a financial quarter. This operational paralysis is the key to understanding the results.
We can trace the cause-and-effect relationship clearly. First, the cyberattack directly halted logistics. Stryker itself confirmed this, filing an 8-K report stating the event had a 'material impact' on its Q1 results. Second, this frames the earnings miss as an internal, operational problem, not a broader market issue. This view is supported by strong results from competitors like Zimmer Biomet and major hospital operators like HCA Healthcare, which indicated that the market for surgical procedures was healthy. A third, more minor factor was the strengthening U.S. dollar, which created a slight headwind for international sales.
Crucially, Stryker announced that its operations were fully restored by early April. This strongly suggests the revenue shortfall from Q1 wasn't lost forever but simply delayed. The narrative now shifts to a Q2 'catch-up' period, where delayed orders are expected to be fulfilled. For investors, the most critical piece of information from the earnings call will be the reaffirmation of the full-year guidance. Maintaining the forecast would signal management's confidence that the cyberattack was a one-time disruption, not a lasting problem.
- EPS (Earnings Per Share): A company's profit divided by its total number of outstanding shares. It is a widely used indicator of a company's profitability.
- 8-K: A report that publicly traded companies in the U.S. must file with the Securities and Exchange Commission (SEC) to announce major events that shareholders should know about.
- FX Headwind: A term used to describe the negative impact of a strengthening domestic currency on a company's foreign earnings. When the U.S. dollar strengthens, sales made in other currencies translate into fewer dollars.